RT Journal Article
SR Electronic
T1 Lexical and acoustic features in speech relating to Alzheimer’s disease pathology
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.27.21264148
DO 10.1101/2021.09.27.21264148
A1 Cho, Sunghye
A1 Cousins, Katheryn A.Q.
A1 Shellikeri, Sanjana
A1 Ash, Sharon
A1 Irwin, David J.
A1 Liberman, Mark
A1 Grossman, Murray
A1 Nevler, Naomi
YR 2021
UL http://medrxiv.org/content/early/2021/09/29/2021.09.27.21264148.abstract
AB INTRODUCTION Over 50% of logopenic variant primary progressive aphasia (lvPPA) cases are associated with AD pathology, yet their speech is not characterized compared to amnestic AD. In this study, we compared AD and lvPPA patients in a biologically confirmed cohort.METHODS We extracted language variables with automated lexical and acoustic pipelines from oral picture descriptions produced by 44 AD and 21 lvPPA patients.RESULTS LvPPA patients produced fewer verbs, adjectives, and more fillers with lower lexical diversity and higher pause rate than AD. Both groups showed some shared language impairments compared to HC, including more frequent and shorter words. Some of these measures were related to clinical test scores and CSF p-tau levels.DISCUSSION Our speech measures captured subtle differences between the two phenotypes. Also, shared speech markers were linked to the common underlying pathology. This work demonstrates the potential of natural speech in detection of underlying AD pathology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by grants from the National Institute of Health (AG066597, AG054519, NS109260, P30 AG072979), Alzheimer's Association (AACSF-18-567131, AARF-D-619473, AARF-D-619473-RAPID), Department of Defense (PR192041).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of the Hospital of the University of Pennsylvania approved the study of human subjects, and all participants agreed to participate in the study by written consent. All digital data was stored in secured HIPAA-compliant servers and handled by personnel trained in PPI protection.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available upon request from appropriate research groups.